Form 4: Encompass Health Director Boosts Stake via Deferred Plan

Encompass Health Director Christopher R. Reidy increased his direct beneficial ownership of company common stock through RSU awards and a deferred stock investment plan.

Summary

• Director Christopher R. Reidy acquired 16 Restricted Stock Units (RSUs) on October 15, 2025, as part of a dividend reinvestment program.
• He also acquired 288 shares of Encompass Health Common Stock on October 15, 2025, through the Directors Deferred Stock Investment Plan.
• The 288 shares were purchased at a weighted average price of $123.23 per share, with prices ranging from $123.19 to $123.24.
• Following these transactions, Reidy directly beneficially owns 15,085 shares of Encompass Health Common Stock.
• The transactions were made pursuant to a Rule 10b5-1(c) plan.

Sentiment

Score: 7

Explanation: The director's increased stake and participation in a deferred compensation plan are positive signals of confidence, though the filing itself is routine and expected.

Positives

• Director Christopher R. Reidy increased his direct beneficial ownership in Encompass Health Corp, signaling confidence in the company's future.
• The acquisition of shares through the Directors Deferred Stock Investment Plan demonstrates management's commitment and alignment with shareholder interests.
• The company paid a common stock dividend of $0.19 per share, indicating ongoing returns to shareholders.

Negatives

• NA

Risks

• NA

Future Outlook

NA

Management Comments

• The reporting person undertakes to provide full information regarding the number of shares purchased at each separate price within the range of $123.19 to $123.24 upon request.

Industry Context

This filing reflects an individual director's investment activity, which is a common occurrence across publicly traded companies where directors often receive equity compensation and participate in deferred compensation plans.

Comparison to Industry Standards

• NA

Management Changes

Corporate Governance

Legal Proceedings

• NA

Related Party Transactions

• NA

Stakeholder Impact

• Shareholders: Director's increased ownership aligns interests with shareholders; dividend payment provides direct return.
• Employees: No direct impact mentioned.
• Customers: No direct impact mentioned.
• Suppliers: No direct impact mentioned.
• Creditors: No direct impact mentioned.

Next Steps

• The reporting person may provide detailed price information for the acquired shares upon request.

Key Dates

Recommendation

This Form 4 filing details routine insider transactions by a director, Christopher R. Reidy, involving the acquisition of shares through a deferred compensation plan and restricted stock units from dividend reinvestment. While the increased stake by a director can be seen as a positive signal of confidence, the transactions are part of pre-established plans (Rule 10b5-1(c) and the Directors Deferred Stock Investment Plan) and do not represent discretionary open-market purchases that would typically indicate a strong new investment thesis. The filing provides no new material information regarding the company's operational performance, strategic direction, or financial health that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate, maintaining current positions while awaiting more substantive corporate updates.

Keywords

EHC, Encompass Health, Form 4, Insider Trading, Director Stock, Stock Acquisition, Restricted Stock Units, Dividend Reinvestment, 10b5-1 Plan